Sevion Therapeutics Inc., a biopharmaceutical company that discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, has entered into an agreement with Malvern Instruments establishing a new biopharmaceutical applications laboratory in the heart of San Diego’s biotechnology cluster. The new laboratory will enable Sevion Therapeutics and customers of Malvern the experience and use of Malvern’s range of specialist biophysical characteriza...